on 02 Apr 2024
Last Applicant/ Owned by
New York NY 10169
Serial Number
79358602 filed on 17th Oct 2022
Registration Number
7341739 registered on 02th Apr 2024
Correspondent Address
Andrew N. Spivak
Filing Basis
1. filing basis filed as 66 a
Disclaimer
"131 I-OMBURTAMAB"
Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of in the field of oncology, chemotherapy, and inflammatory diseases, namely antRead More
Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of in the field of oncology, chemotherapy, and inflammatory diseases, namely antibodies; industrial analysis and research services in the field of chemistry, namely antibodies
Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; all of the aforesaid containing monoclonal antibodies
No 79358602
No Service Mark
No 26691
No
No
No
No
Yes
Yes
No
No
26.05.14 -
Three triangles
26.05.21 -
Triangles that are completely or partially shaded
26.13.14 -
Three or more quadrilaterals
26.13.21 -
Quadrilaterals that are completely or partially shaded
The mark consists of the wording "OMBLASTYS" and "(131 I-OMBURTAMAB-YCWD)". The word "OMBLASTYS" is in turquoise and appears in the middle of the figure mark. Below the word "OMBLASTYS" appears the second-word element "(131 I-OMBURTAMAB-YCWD)" in gray. In the top right corner of the mark just above "YS" in the word element "OMBLASTYS" a figure element appears. The shape element consists of three rhombuses right after each other at the top, where the first is in dark blue, and the one next to it is in dark green, and the next one next to it is in light green. Below these appear 5 triangles, the first, third and fifth are the same size, and the second and fourth are the same size but appear smaller than the first, third and fifth. The first triangle is in dark blue, and the second is also in dark blue. The third triangle is in the middle is turquoise. The penultimate fourth triangle is dark green. The last triangle is in green. The color white represents background, outlining, shading and/or transparent areas and are not part of the mark.
| Status Date | Action Taken |
|---|---|
| 02th Apr 2024 | REGISTERED-PRINCIPAL REGISTER |
| 02th Apr 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 16th Jan 2024 | PUBLISHED FOR OPPOSITION |
| 16th Jan 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 13th Jan 2024 | NOTIFICATION PROCESSED BY IB |
| 27th Dec 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 27th Dec 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 27th Dec 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 09th Dec 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 08th Dec 2023 | EXAMINERS AMENDMENT -WRITTEN |
